Tagged With "Novartis"

Blog Post

Promacta® Oral Suspension Recalled for Possible Peanut Contamination

AAFA Community Services ·
Novartis today announced a voluntary recall of three lots of Promacta (eltrombopag) 12.5 mg for oral suspension to the consumer level. The oral suspension lots are being recalled because of a risk of potential peanut flour contamination that occurred at a third-party contract manufacturing site.
×
×
×
×